PTC Therapeutics Newsroom

RBC Capital Sticks to Its Hold Rating for PTC Therapeutics (PTCT)

TipRanksMay 22 21:45 ET

Form 144 | PTC Therapeutics(PTCT.US) Director Proposes to Sell 764.77K in Common Stocks

SEC FILLINGS DISCLOSED/ May 22, $PTC Therapeutics(PTCT.US)$ Director ZELDIS JEROME B intends to sell 20,000 shares of its common stock on May 22, with a total market value of approximately $764.77K.

moomoo NewsMay 22 10:15 ET

Analysts' Revenue Estimates For PTC Therapeutics, Inc. (NASDAQ:PTCT) Are Surging Higher

PTC Therapeutics, Inc. (NASDAQ:PTCT) shareholders will have a reason to smile today, with the analysts making substantial upgrades to this year's statutory forecasts. The consensus estimated revenue

Simply Wall StMay 22 06:49 ET

Hold Rating on PTC Therapeutics Amid Regulatory Uncertainty for Translarna

TipRanksMay 22 00:55 ET

PTC Therapeutics (PTCT) Up as EC Returns CHMP Opinion on DMD Drug

Yahoo FinanceMay 21 12:26 ET

PTC Therapeutics Price Target Raised to $53.00/Share From $43.00 by JP Morgan

PTC Therapeutics Price Target Raised to $53.00/Share From $43.00 by JP Morgan

Dow JonesMay 21 12:17 ET

PTC Therapeutics Is Maintained at Sell by Goldman Sachs

PTC Therapeutics Is Maintained at Sell by Goldman Sachs

Dow JonesMay 21 10:25 ET

Express News | Goldman Sachs Maintains Sell on PTC Therapeutics, Raises Price Target to $32

BenzingaMay 21 10:15 ET

Express News | European Commission Asked CHMP To Review Its January Opinion On Renewal Of Marketing Authorization For Translarna

BenzingaMay 21 08:46 ET

Express News | EMA : European Commission Asked Chmp to Review Its January Opinion on Renewal of Marketing Authorisation for Translarna

ReutersMay 21 08:44 ET

Express News | PTC Therapeutics Inc : Citigroup Raises Target Price to $26 From $18

ReutersMay 21 06:12 ET

Analysts Conflicted on These Healthcare Names: Ionis Pharmaceuticals (IONS), Conmed (CNMD) and PTC Therapeutics (PTCT)

TipRanksMay 21 05:42 ET

Express News | PTC Therapeutics Inc : Raymond James Raises to Market Perform From Underperform

ReutersMay 20 23:49 ET

Express News | PTC Therapeutics Inc : JP Morgan Raises Target Price to $53 From $43

ReutersMay 20 23:31 ET

Translarna's Uncertain Future: Justifying a Sell Rating for PTC Therapeutics

TipRanksMay 20 19:15 ET

Larimar Stock Rallies 24% on FDA Removal of Partial Clinical Hold

Seeking AlphaMay 20 18:17 ET

Sell Rating Maintained for PTC Therapeutics Amid Long-Term Revenue Growth Concerns

TipRanksMay 20 14:45 ET

PTC Therapeutics Is Maintained at Buy by Jefferies

PTC Therapeutics Is Maintained at Buy by Jefferies

Dow JonesMay 20 13:44 ET

Express News | Jefferies Maintains Buy on PTC Therapeutics, Raises Price Target to $46

BenzingaMay 20 13:35 ET

PTC Therapeutics Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/20/2024 15.81% Jefferies $35 → $46 Maintains Buy 04/29/2024 -24.47% Morgan Stanley $28 → $30 Upgrades U

BenzingaMay 20 13:33 ET